연구

연구업적

최근 5년 연구업적 현황
연도 2022년 2021년 2020년 2019년 2018년
SCI 논문
발표편수
책임 163편 184편 135편 144편 124편
공동 115편 136편 168편 167편 120편
합계 278편 320편 303편 311편 244편
2818. Deep Learning to Optimize Candidate Selection for Lung Cancer CT Screening: Advancing the 2021 USPSTF Recommendations.
Lee JH, Lee D, Lu MT, Raghu VK, Park C.M, Goo JM, Choi SH, Kim H
Radiology. 2022 Oct;305(1):209-218. Link
2817. No Prognostic Impact of Staging Brain MRI in Patients with Stage IA Non-Small Cell Lung Cancer.
Nam JG, Hong H, Choi SH, Park CM, Goo JM, Kim YT, Kim H.
Radiology. 2022 Jun;303(3):632-643. Link
2816. Deep Learning for Detecting Pneumothorax on Chest Radiographs after Needle Biopsy: Clinical Implementation.
Hong W, Hwang EJ, Lee JH, Park J, Goo JM, Park CM
Radiology. 2022 May;303(2):433-441. Link
2815. Subcellular progression of mesenchymal transition identified by two discrete synchronous cell lines derived from the same glioblastoma
Sojin Kim # 1 2, Soo-Ji Park # 3 4, Tamrin Chowdhury # 1, Jeong-Im Hong 3, Jinhee Ahn 3, Tae Yeong Jeong 3 4, Hyeon Jong Yu 1, Young-Kyoung Shin 5, Ja-Lok Ku 5, Jong Bae Park 6, Junho K Hur 7, Hwajin Lee 8, Kyoungmi Kim 9 10, Chul-Kee Park 11 12
Cell Mol Life Sci. 2022 Mar 12;79(3):181. Link
2814. The telomere maintenance mechanism spectrum and its dynamics in gliomas
Sojin Kim # 1, Tamrin Chowdhury # 1 2, Hyeon Jong Yu 1 2, Jee Ye Kahng 2, Chae Eun Lee 1, Seung Ah Choi 1 3, Kyung-Min Kim 1 2, Ho Kang 1 2, Joo Ho Lee 2 4, Soon-Tae Lee 2 5, Jae-Kyung Won 2 6, Kyung Hyun Kim 1 3, Min-Sung Kim 1, Ji Yeoun Lee 1 3 7, Jin Wook Kim 1 2, Yong-Hwy Kim 1 2, Tae Min Kim 2 8, Seung Hong Choi 2 9, Ji Hoon Phi 2 3, Young-Kyoung Shin 2 10, Ja-Lok Ku 2 10, Sungyoung Lee 11, Hongseok Yun 11, Hwajin Lee 12, Dokyoung Kim 13, Kyoungmi Kim 14, Junho K Hur 15, Sung-Hye Park 2 6,
Genome Med. 2022 Aug 11;14(1):88 Link
2813. Involvement of cell shape and lipid metabolism in glioblastoma resistance to temozolomide
Munki Choo 1, Van-Hieu Mai 1, Han Sun Kim 1, Dong-Hwa Kim 1, Ja-Lok Ku 2, Sang Kook Lee 1, Chul-Kee Park 3, Yong Jin An 4, Sunghyouk Park 5
Acta Pharmacol Sin. 2022 Sep 13. Link
2812. Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study.
Carpenter PA, Kang HJ, Yoo KH, Zecca M, Cho B, Lucchini G, Nemecek ER, Schultz KR, Stepensky P, Chaudhury S, Oshrine B, Khaw SL, Harris AC, Verna M, Zubarovskaya L, Lee Y, Wahlstrom J, Styles L, Shaw PJ, Dalle JH.
Transplant Cell Ther, 2022 Nov, 28(11):771.e1-771.e10. Link
2811. Clinical Characteristics and Prognosis of the Modified Probable Pneumocystis jirovecii Pneumonia in Korean Children, 2001-2021.
Yun KS, Anh B, Choi SH, Hong KT, Choi JY, Yun KW, Kang HJ, Choi EH.
Children (Basel), 2022 Oct, 9(10):1596. Link
2810. Clinical Outcome of Optic Pathway and Hypothalamic Gliomas: A 20-Year Single-Institution Retrospective Study.
Kim JW, Phi JH, Lee JY, Koh EJ, Kim KH, Kang HJ, Choi JY, Park SH, Wang KC, Kim SK.
World Neurosurg, 2022 Oct, 166:e451-e459. Link
2809. Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors.
Doz F, van Tilburg CM, Geoerger B, Højgaard M, Øra I, Boni V, Capra M, Chisholm J, Chung HC, DuBois SG, Gallego-Melcon S, Gerber NU, Goto H, Grilley-Olson JE, Hansford JR, Hong DS, Italiano A, Kang HJ, Nysom K, Thorwarth A, Stefanowicz J, Tahara M, Ziegler DS, Gavrilovic IT, Norenberg R, Dima L, De La Cuesta E, Laetsch TW, Drilon A, Perreault S.
Neuro Oncol. 2021 Nov 27, 2022 Jun, 24(6):997-1007. Link